![Case 6-1992 — A 67-Year-Old Man with Aphasia and Memory Loss, Followed by Progressive Dementia | NEJM Case 6-1992 — A 67-Year-Old Man with Aphasia and Memory Loss, Followed by Progressive Dementia | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1992/nejm_1992.326.issue-6/nejm199202063260608/production/images/img_medium/nejm199202063260608_f1.jpeg)
Case 6-1992 — A 67-Year-Old Man with Aphasia and Memory Loss, Followed by Progressive Dementia | NEJM
Full article: β-glucan, “the knight of health sector”: critical insights on physiochemical heterogeneities, action mechanisms and health implications
![Phase Separation: “The Master Key” to Deciphering the Physiological and Pathological Functions of Cells - Wei - 2022 - Advanced Biology - Wiley Online Library Phase Separation: “The Master Key” to Deciphering the Physiological and Pathological Functions of Cells - Wei - 2022 - Advanced Biology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d2c04a85-749e-4be7-9a17-dc711dff1da1/adbi202200006-fig-0001-m.jpg)
Phase Separation: “The Master Key” to Deciphering the Physiological and Pathological Functions of Cells - Wei - 2022 - Advanced Biology - Wiley Online Library
![Necrotizing enterocolitis induces T lymphocyte–mediated injury in the developing mammalian brain | Science Translational Medicine Necrotizing enterocolitis induces T lymphocyte–mediated injury in the developing mammalian brain | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aay6621/asset/4eee9d24-1fcc-423c-823b-5ec87ba8f4d1/assets/graphic/aay6621-f1.jpeg)
Necrotizing enterocolitis induces T lymphocyte–mediated injury in the developing mammalian brain | Science Translational Medicine
Sodexo Benefity - Nově spouštíme službu ➡️ SodexoRozvoz ⬅️, díky které můžete na Jídlo a Čas, Košík.cz a Eat Perfect by Filip Sajler platit stravenkovou kartou Gastro Pass CARD. A chystáme třeba
![Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 | Nature Medicine Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01310-z/MediaObjects/41591_2021_1310_Fig1_HTML.png)